Warner-Lambert v Sandoz and Lloyds Pharmacy, High Court
The High Court has granted interim injunctions preventing Sandoz from trading in full label generic pregabalin and Lloyds Pharmacy from dispensing such product.
The case concerns the pharmaceutical product, pregabalin, marketed by Pfizer under the brand name, Lyrica. Warner-Lambert, which is part of the Pfizer group, […]
The European Commission has put forward plans for a waiver of supplementary protection certificates (SPCs) to stimulate pharmaceutical manufacturing in Europe. The proposal would remove obstacles to the competitiveness of EU industry by allowing the manufacture for export of generics and biosimilars, which are protected by SPCs in Europe, but not in the non-EU country […]
An on-going shortage in skills of candidates for senior roles is leading to dangers in the UK’s standing in innovation in pharma. This depressing analysis has come from none other than the Association of the British Pharmaceutical Industry, the body representing big pharma in the UK. Pharma businesses are being forced to look abroad […]
Seven pharma businesses are in the top 100 for innovation, according to Thomson Reuters. The seven are Johnson & Johnson, Novartis, Roche, Abbott, Bayer, Bristol-Myers Squibb and Boehringer Ingelheim.
The business intelligence company’s report says: “As genomics drives the era of precision medicine and more and more therapies are being developed to specifically […]